000 | 01968 a2200505 4500 | ||
---|---|---|---|
005 | 20250514071415.0 | ||
264 | 0 | _c20031006 | |
008 | 200310s 0 0 eng d | ||
022 | _a0960-8966 | ||
024 | 7 |
_a10.1016/s0960-8966(03)00029-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAnderson, Judy E | |
245 | 0 | 0 |
_aCorrelated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment. _h[electronic resource] |
260 |
_bNeuromuscular disorders : NMD _cJun 2003 |
||
300 |
_a388-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aArginine _xpharmacology |
650 | 0 | 4 | _aBlotting, Northern |
650 | 0 | 4 | _aDNA-Binding Proteins |
650 | 0 | 4 |
_aDiaphragm _xmetabolism |
650 | 0 | 4 |
_aDystrophin _xdeficiency |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 | _aIn Situ Hybridization |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred mdx |
650 | 0 | 4 |
_aMuscle Fibers, Skeletal _xmetabolism |
650 | 0 | 4 |
_aMuscle Proteins _xgenetics |
650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
650 | 0 | 4 |
_aMuscular Dystrophies _xmetabolism |
650 | 0 | 4 | _aMyogenic Regulatory Factor 5 |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aPregnenediones _xpharmacology |
650 | 0 | 4 | _aProtein Isoforms |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-met _xmetabolism |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 |
_aRegeneration _xdrug effects |
650 | 0 | 4 |
_aSatellite Cells, Skeletal Muscle _xdrug effects |
650 | 0 | 4 |
_aTrans-Activators _xmetabolism |
700 | 1 | _aVargas, Cinthya | |
773 | 0 |
_tNeuromuscular disorders : NMD _gvol. 13 _gno. 5 _gp. 388-96 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0960-8966(03)00029-4 _zAvailable from publisher's website |
999 |
_c12583368 _d12583368 |